Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anavex Life Sciences

8.95
+0.11001.24%
Post-market: 8.90-0.0500-0.56%19:03 EDT
Volume:350.84K
Turnover:3.11M
Market Cap:761.32M
PE:-16.20
High:8.99
Open:8.81
Low:8.70
Close:8.84
Loading ...
Jun 24, 2021

Major Issues Report

8-K - Current report
May 28, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 09, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 28, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 28, 2020

Major Issues Report

8-K - Current report
Dec 15, 2020

Major Issues Report

8-K - Current report
Nov 06, 2020

Major Issues Report

8-K - Current report
Oct 15, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 02, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Apr 08, 2020

Major Issues Report

Current report, item 5.07
Mar 09, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals